Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

982 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.
Dominici M, Nichols K, Srivastava A, Weiss DJ, Eldridge P, Cuende N, Deans RJ, Rasko JE, Levine AD, Turner L, Griffin DL, O'Donnell L, Forte M, Mason C, Wagena E, Janssen W, Nordon R, Wall D, Ho HN, Ruiz MA, Wilton S, Horwitz EM, Gunter KC; 2013–2015 ISCT Presidential Task Force on Unproven Cellular Therapy. Dominici M, et al. Among authors: wall d. Cytotherapy. 2015 Dec;17(12):1663-6. doi: 10.1016/j.jcyt.2015.10.007. Cytotherapy. 2015. PMID: 26589750 No abstract available.
Advances in automated cell washing and concentration.
Li A, Kusuma GD, Driscoll D, Smith N, Wall DM, Levine BL, James D, Lim R. Li A, et al. Among authors: wall dm. Cytotherapy. 2021 Sep;23(9):774-786. doi: 10.1016/j.jcyt.2021.04.003. Epub 2021 May 27. Cytotherapy. 2021. PMID: 34052112 Free article. Review.
Isolex 300i CD34-selected cells to support multiple cycles of high-dose therapy.
Prince HM, Bashford J, Wall D, Rischin D, Parker N, Toner GC, Seymour JF, Blakey D, Haylock D, Simmons P, Francis P, Wolf M, Januszewicz EH, Richardson G, Scarlett J, Briggs P. Prince HM, et al. Among authors: wall d. Cytotherapy. 2002;4(2):137-45. doi: 10.1080/146532402317381848. Cytotherapy. 2002. PMID: 12006209 Clinical Trial.
CliniMACS CD34-selected cells to support multiple cycles of high-dose therapy.
Prince HM, Wall D, Rischin D, Toner GC, Seymour JF, Blakey D, Haylock D, Simmons P, Wolf M, Januszewicz EH, Westerman D, Richardson G, Scarlett J, Briggs P. Prince HM, et al. Among authors: wall d. Cytotherapy. 2002;4(2):147-55. doi: 10.1080/146532402317381857. Cytotherapy. 2002. PMID: 12006210 Clinical Trial.
Considerations for the development of iPSC-derived cell therapies: a review of key challenges by the JSRM-ISCT iPSC Committee.
Madrid M, Lakshmipathy U, Zhang X, Bharti K, Wall DM, Sato Y, Muschler G, Ting A, Smith N, Deguchi S, Kawamata S, Moore JC, Makovoz B, Sullivan S, Falco V, Al-Riyami AZ. Madrid M, et al. Cytotherapy. 2024 Nov;26(11):1382-1399. doi: 10.1016/j.jcyt.2024.05.022. Epub 2024 Jun 12. Cytotherapy. 2024. PMID: 38958627 Free article. Review.
982 results